Xanodyne Pharmaceuticals is out to create a medicinal Xanadu. The company primarily develops and manufactures drugs for pain management. Its commercial offerings include pain treatments Hycet, Roxicodone, Oramorph SR, and Zipsor. In addition, the company markets the Duet and Stuart lines of prenatal vitamins. Xanodyne has several other drugs in development, including one for mild to moderate pain in late-stage clinical trials. The firm funds its development efforts through sales of its commercial products, which are marketed through an internal specialty sales force that targets pain specialists and women's healthcare physicians in the US.